Z11. COVID-19 Vaccines
Poster Session: COVID-19: Vaccines
Chloé Wyndham-Thomas, PhD (she/her/hers)
Senior Epidemiologist
P95 Epidemiology and Pharmacovigilance
Leuven, Vlaams-Brabant, Belgium
E. Claire Newbern, PhD
Janssen Research & Development, LLC
Horsham, Pennsylvania, United States
Ainara Mira-Iglesias, PhD
Fisabio Public-Health
Valencia, Comunidad Valenciana, Spain
Akshat Dwivedi, MSc
P95 Epidemiology and Pharmacovigilance
Leuven, Brabant Wallon, Belgium
Alejandro Orrico-Sánchez
Senior Manager
FISABIO-Public Health
Valencia, Comunidad Valenciana, Spain
Andrés Antón, PhD
Hospital Universitario Vall d’Hebrón
Barcelona, Catalonia, Spain
Charlotte Martin, PhD
Le Centre Hospitalier Universitaire St Pierre
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Giancarlo Icardi, MD
University of Genoa, San Martino Policlinico Hospital
Genoa, Liguria, Italy
Irma Casas, PhD
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, Spain
Kok Yew Ngew, MSc
P95 Epidemiology and Pharmacovigilance
Leuven, Brabant Wallon, Belgium
Laura Drikite, MSc
P95 Epidemiology and Pharmacovigilance
Leuven, Brabant Wallon, Belgium
Leonie de Munter, PhD
P95 Epidemiology and Pharmacovigilance
Leuven, Brabant Wallon, Belgium
Gerrit Luit ten Kate, PhD
Universitair Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium
Nikki Vroom, MSc
P95 Epidemiology and Pharmacovigilance
Leuven, Brabant Wallon, Belgium
Sebastian Baumgartner, MD
Klinik Favoriten
Wien, Wien, Austria
Susana Otero-Romero, PhD
Hospital Universitario Vall d’Hebrón
Barcelona, Catalonia, Spain
Xavier Holemans, MD
Grand Hôpital de Charleroi
Charleroi, Hainaut, Belgium
Kaatje Bollaerts, PhD
P95 Epidemiology and Pharmacovigilance
Leuven, Brabant Wallon, Belgium
Nicolas Praet, PhD
Janssen Research & Development, LLC
Beerse, Antwerpen, Belgium